SCIENCE@home

Redefining the role of bronchoscopy in the work-up of severe uncontrolled asthma in the era of biologics: a prospective study.

B. Cosío,H. Shafiek,M. Mosteiro,A. Iglesias,C. Gómez,Nuria Toledo-Pons,Rocío Martínez,Meritxell López,Inés Escribano Gimeno,Luis Pérez de Llano

Published 2023 in Chest

ABSTRACT

BACKGROUND Severe uncontrolled asthma (SUA) is frequently treated with biologic therapy if a T2 phenotype is found. Bronchoscopy is not routinely recommended in these patients unless a specific indication to rule out comorbidities is present. RESEARCH QUESTION Is routine bronchoscopy safe and useful in phenotyping and endotyping SUA patients prior to the indication of a biologic therapy?. STUDY DESIGN AND METHODS Prospective study of consecutive SUA patients who were referred to a specialized asthma clinic to assess the indication of a biologic therapy. Patients were clinically phenotyped as T2-allergic, T2-eosinophilic and non-T2. All patients underwent bronchoscopy and systematic data collection of endoscopic findings, microbiology of bronchial aspirate (BAS) and presence of eosinophils in bronchial biopsy were recorded and compared between asthma phenotypes. Cluster analysis was performed accordingly. RESULTS One-hundred patients were recruited and classified as T2-allergic (28%), T2-eosinophilic (64%) and non-T2 (8%). On bronchoscopy, signs of gastroesophageal reflux disease were detected in 21%, vocal cord dysfunction in 5% and tracheal abnormalities in 3%. BAS culture isolated bacteria in 27% of patients, and fungi in 14%. Three clusters were identified: non-specific, upper airway, and infection being the latter less frequently associated to submucosal eosinophilia. Eosinophils were detected in 91% of bronchial biopsies. Despite a correlation to blood eosinophils, five patients with T2-phenotypes showed no eosinophils in bronchial biopsy, and 3 patients with non-T2 showed eosinophils in bronchial biopsy. Only one patient had a moderate bleeding. INTERPRETATION Routine bronchoscopy in SUA eligible for biologic therapy is a safe procedure that can help to better phenotype and personalize asthma management.

PUBLICATION RECORD

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-26 of 26 references · Page 1 of 1

CITED BY

Showing 1-17 of 17 citing papers · Page 1 of 1